Advertisements


Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO

The blockbuster public offering pegs Allogene's market value at more than $2 billion. Biotech’s red-hot IPO streak shows no signs of slowing down. In fact, on Thursd.....»»

Category: europeSource: fortuneOct 11th, 2018

Drive-backed gene therapy startup raises $120M to amp up biotech manufacturing in Grove City

A gene therapy startup that launched last summer has raised $120 million toward expanding its biotech manufacturing capacity in Grove City. It's the largest Series B financing in Ohio history, according to PitchBook......»»

Category: topSource: bizjournalsApr 29th, 2021

Rain Therapeutics raises $125M in 5th Bay Area life science IPO in 8 days

Rain Therapeutics Inc. was set on Friday to be the fifth Bay Area life science company in eight days to debut on Nasdaq. The Newark cancer therapeutics business raised $125 million in an initial public offering that hit the middle of its price .....»»

Category: topSource: bizjournalsApr 23rd, 2021

Explosive Bay Area biotech raises $500M in upsized IPO

The eight-year-old company has hired nearly 800 people, raised more than $870 million and plans to move into one of the East Bay's most iconic spaces as it rolls out an atypical range of products faster, cheaper and in a more environmentally safe way......»»

Category: personnelSource: nytApr 23rd, 2021

Arizona Gives Day raises millions to help nonprofits recover from pandemic

The annual statewide fundraiser scored $1 million more this year than in 2020, with five organizations each raising $7,500......»»

Category: topSource: bizjournalsApr 21st, 2021

ADVAXIS MAKING BOLD STEPS IN NEW CANCER STUDIES AND AGREEMENT WITH COLUMBIA UNIVERSITY

Advaxis, Inc. (NASDAQ: ADXS), CEO Ken Berlin presented at the Benzinga Biotech Small-Cap Conference on March 24, 2021. read more.....»»

Category: blogSource: benzingaApr 20th, 2021

Biomea Fusion"s upsized IPO prices at top of expected range, to value the biotech at $464 million

Biomea Fusion Inc. was set to go public Friday, as the California-.....»»

Category: topSource: marketwatchApr 16th, 2021

Beauty biotech Amyris makes two deals with AI, Gen-Z upside

The company has invested about $12 million in acquiring and developing new brands this year, the CEO said......»»

Category: topSource: bizjournalsApr 15th, 2021

Exclusive: Precigen"s CEO Breaks Down Biotech"s Oncology Platforms, Technology, Differentiators

Cancer treatment has evolved from the use of chemotherapeutic anti-tumor drugs to targeted therapies to monoclonal antibodies to immunotherapies to new, personalized therapeutics. read more.....»»

Category: blogSource: benzingaApr 6th, 2021

Biotech company spun out of Ohio State University research raises $116M in latest round

When it was founded back in 2018, Entrada raised $59 million, which was the largest amount raised in an initial financing round for an OSU startup......»»

Category: topSource: bizjournalsApr 5th, 2021

Kintara Taking The Lead In Developing New And Innovative Rare Cancer Therapies

Kintara Therapeutics, Inc. Chief Executive Officer Saiid Zarrabian participated in the Benzinga Biotech Small Cap Conference held March 24-25, 2021.  read more.....»»

Category: blogSource: benzingaApr 5th, 2021

The Week Ahead In Biotech: Regeneron, Supernus FDA Decisions, Cancer Conference Presentations In The Spotlight

Biotech stocks ended the holiday-shortened week ended April 1 in the green, catalyzed by the broader market rebound and a slew of company-specific news flow. Buoyed by hopes of a U.S. read more.....»»

Category: blogSource: benzingaApr 3rd, 2021

Economic Report: Unemployment applications fall below 1 million for first since pandemic, but it’s no time to celebrate

The number of Americans losing their jobs each week appears to have fallen to a pandemic low, but it's no time to start popping champagne corks......»»

Category: topSource: marketwatchMar 25th, 2021

Armed with $72 million, startup targeting cancer expands to Durham

After a nationwide search, the company found its chief scientific officer in Durham. Now, it's expanding to the region......»»

Category: topSource: bizjournalsMar 18th, 2021

Laryngeal Cancer Therapeutics Market To See $635M Growth By 2025 And These 2 Companies Will Be Key Drivers: Research

The global laryngeal cancer therapeutics market is expected to grow by $635.07 million during 2021-2025 helped by Amgen Inc (NASDAQ: AMGN) and AstraZeneca Plc (NYSE: AZN) as key contributors to growth, acco.....»»

Category: blogSource: benzingaMar 18th, 2021

Eye-popping stats about Roblox, the wildly popular game platform that"s going public Wednesday

As of September, Roblox's gaming platform had more than 30 million daily active users flocking to its mor.....»»

Category: dealsSource: nytMar 10th, 2021

With pivot to cancer drug company, Peninsula biotech lines up $117M funding

The money represents only the second funding round in the company's 15 years......»»

Category: topSource: bizjournalsMar 5th, 2021

Realtor.com: John Travolta is selling his massive waterfront mansion in Maine for $5 million

The actor John Travolta is selling his massive, oceanfront Maine mansion for $5 million. The star had owned the longtime retreat with his wife, the actress Kelly Preston, who died last year at the age of 57 of breast cancer......»»

Category: topSource: marketwatchFeb 24th, 2021

University Hospitals building a new cancer center in NE Ohio

The $31 million, 35,000 square-foot, two-floor facility will offer both radiation and medical oncology services......»»

Category: topSource: bizjournalsFeb 19th, 2021

: Fernando Tatis Jr. to sign 14-year, $340 million megadeal with Padres: report

Fernando Tatis Jr., already one of the most exciting players in baseball, reportedly has an eye-popping contract to match......»»

Category: topSource: marketwatchFeb 17th, 2021

The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) read more.....»»

Category: blogSource: benzingaFeb 17th, 2021